MX9709695A - Emulsion liquida de fluorocarbono como reserva vascular de oxido nitrico. - Google Patents
Emulsion liquida de fluorocarbono como reserva vascular de oxido nitrico.Info
- Publication number
- MX9709695A MX9709695A MX9709695A MX9709695A MX9709695A MX 9709695 A MX9709695 A MX 9709695A MX 9709695 A MX9709695 A MX 9709695A MX 9709695 A MX9709695 A MX 9709695A MX 9709695 A MX9709695 A MX 9709695A
- Authority
- MX
- Mexico
- Prior art keywords
- nitric oxide
- liquid fluorocarbon
- fluorocarbon emulsion
- oxide reservoir
- utilized
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title abstract 8
- 239000000839 emulsion Substances 0.000 title abstract 3
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 title abstract 2
- 230000002792 vascular Effects 0.000 title 1
- 108010054147 Hemoglobins Proteins 0.000 abstract 1
- 102000001554 Hemoglobins Human genes 0.000 abstract 1
- 108010061951 Methemoglobin Proteins 0.000 abstract 1
- 206010057469 Vascular stenosis Diseases 0.000 abstract 1
- 206010047139 Vasoconstriction Diseases 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- 230000025033 vasoconstriction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Las emulsiones de fluorocarbono compatibles se utilizan para inhibir la remocion del oxido nítrico endogeno del flujo de sangre, y por lo tanto inhibir la estenosis vascular, la vasocontriccion, y cualquier otra condicion fisiologica de alteracion que surja en totalidad o en parte por la deficiencia de oxido nítrico endogeno. Las emulsiones de fluorocarbono líquido también se utilizan para mejorar la efectividad de la hemoglobina administrada de forma intravenosa al limitar la hablilidad de la metahemoglobina que forma el oxido nítrico disuelto en el plasma.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08501976 | 1995-06-07 | ||
| US08/501,976 US5726209A (en) | 1995-06-07 | 1995-06-07 | Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9709695A true MX9709695A (es) | 1998-06-28 |
| MXPA97009695A MXPA97009695A (es) | 1998-10-30 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9900900A2 (hu) | 1999-08-30 |
| AU718120B2 (en) | 2000-04-06 |
| PL323821A1 (en) | 1998-04-27 |
| IL122261A0 (en) | 1998-04-05 |
| US5726209A (en) | 1998-03-10 |
| CA2221965A1 (en) | 1996-12-19 |
| CN1192136A (zh) | 1998-09-02 |
| WO1996040058A3 (en) | 1997-02-13 |
| KR19990022586A (ko) | 1999-03-25 |
| EP0831776A2 (en) | 1998-04-01 |
| NO975322D0 (no) | 1997-11-19 |
| IL122261A (en) | 2001-09-13 |
| AU6161596A (en) | 1996-12-30 |
| WO1996040058A2 (en) | 1996-12-19 |
| NO975322L (no) | 1998-01-09 |
| JPH11507351A (ja) | 1999-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Levy et al. | Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1 | |
| KR910016317A (ko) | 이온전기도입에 의한 딜리버리를 증가시키는 방법 및 여기에 사용되는 조성물 | |
| ATE185548T1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
| PT707487E (pt) | Metodos e composicoes farmaceuticas uteis no tratamento de disturbios neurologicos | |
| NZ239558A (en) | Pharmaceutical compositions containing perfluorinated hydrocarbons and silicones as liquid carriers | |
| EP2186902A3 (en) | Medical preparations for the treatment of alpha-galactosidase a deficiency | |
| BG97678A (en) | Beta -carotene and/or vitamin e therapy for inhibition of major vascular events | |
| ATE203546T1 (de) | Lagerstabile hämoglobinlösungen | |
| MX9603925A (es) | Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas. | |
| KR960700059A (ko) | 파킨슨씨 병 및 파킨슨 중후군의 치료에 카르바마제핀 및 옥스카르바제핀의 이용(application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes) | |
| WO1996040058A3 (en) | Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir | |
| DE69821498D1 (de) | Verwendung von amifostin | |
| ATE81467T1 (de) | Immunosuppression bei der auf immunotoxin basierten behandlung von menschen. | |
| DK0563127T3 (da) | Forbedret behandlingsfremgangsmåde til cancer | |
| EP0147185A3 (en) | Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine | |
| HK1035330A1 (en) | Use of histamine for elevating blood histamine levels | |
| EA200400348A1 (ru) | Цисплатиновые составы пониженной токсичности и способы их применения | |
| EP0784983A3 (en) | Use of extracellular hemoglobin | |
| Zalewski et al. | Protection of the ischemic myocardium during percutaneous transluminal coronary angioplasty | |
| MX9804343A (es) | Aplicacion dirigida de dosificaciones de agentes medicinales y terapeuticos y otros glicosaminoglicanos (gags). | |
| KR900017599A (ko) | 종양 치료용 약학 조성물 | |
| Loeliger | Does dipyridamole have antithrombotic potential? | |
| Bedingfield | Investigation of a possible role for peripheral opioid receptors in ethanol aversion and reward. | |
| RU93014293A (ru) | Способ лечения хронического бронхита | |
| Mirtallo et al. | A key to the literature of total parenteral nutrition: update 1987 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |